Phase Genomics, Inc. — Form D
Phase Genomics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-22. The offering totals $1.4M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-22
- Form: D
- Accession: 0001722760-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.0M
- Remaining: $400K
- Investors: 4
- Date of first sale: 2017-11-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-299384
Issuer
- Name: Phase Genomics, Inc.
- CIK: 0001722760
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1617 8th Ave. North, SEATTLE, WA, 98109
- Phone: 206-384-6228
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Shawn Sullivan | Executive Officer | Seattle, WA |
| Shawn Sullivan | Promoter | Seattle, WA |
| Ivan Liachko | Director | Seattle, WA |
| Ivan Liachko | Executive Officer | Seattle, WA |
| Ivan Liachko | Promoter | Seattle, WA |
| Kayla Young | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More